Wockhardt Yönetim
Yönetim kriter kontrolleri 4/4
Wockhardt CEO'su Murtaza Khorakiwala, Apr2009 tarihinde atandı, in görev süresi 15.58 yıldır. in toplam yıllık tazminatı ₹ 21.20M olup, şirket hissesi ve opsiyonları dahil olmak üzere 95.3% maaş ve 4.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.18% ine doğrudan sahiptir ve bu hisseler ₹ 380.82M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 15.6 yıl ve 7.5 yıldır.
Anahtar bilgiler
Murtaza Khorakiwala
İcra Kurulu Başkanı
₹21.2m
Toplam tazminat
| CEO maaş yüzdesi | 95.3% |
| CEO görev süresi | 15.6yrs |
| CEO sahipliği | 0.2% |
| Yönetim ortalama görev süresi | 15.6yrs |
| Yönetim Kurulu ortalama görev süresi | 7.5yrs |
Son yönetim güncellemeleri
Recent updates
Wockhardt Limited's (NSE:WOCKPHARMA) Shares Climb 29% But Its Business Is Yet to Catch Up
Nov 02
What Wockhardt Limited's (NSE:WOCKPHARMA) 27% Share Price Gain Is Not Telling You
Aug 20Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jul 27Wockhardt Limited (NSE:WOCKPHARMA) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Jun 30Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation
Jun 22Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%
Feb 21There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump
Dec 19There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues
Oct 14Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Feb 18Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being
Jul 26Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
May 18Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Jan 26
What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?
Dec 01CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -₹3b |
| Jun 30 2024 | n/a | n/a | -₹3b |
| Mar 31 2024 | ₹21m | ₹20m | -₹5b |
| Dec 31 2023 | n/a | n/a | -₹5b |
| Sep 30 2023 | n/a | n/a | -₹5b |
| Jun 30 2023 | n/a | n/a | -₹6b |
| Mar 31 2023 | ₹24m | ₹23m | -₹6b |
| Dec 31 2022 | n/a | n/a | -₹6b |
| Sep 30 2022 | n/a | n/a | -₹5b |
| Jun 30 2022 | n/a | n/a | -₹3b |
| Mar 31 2022 | ₹24m | ₹17m | -₹2b |
| Dec 31 2021 | n/a | n/a | -₹787m |
| Sep 30 2021 | n/a | n/a | -₹567m |
| Jun 30 2021 | n/a | n/a | -₹867m |
| Mar 31 2021 | ₹24m | ₹24m | -₹3b |
| Dec 31 2020 | n/a | n/a | -₹2b |
| Sep 30 2020 | n/a | n/a | -₹3b |
| Jun 30 2020 | n/a | n/a | -₹3b |
| Mar 31 2020 | ₹24m | ₹24m | -₹2b |
| Dec 31 2019 | n/a | n/a | -₹1b |
| Sep 30 2019 | n/a | n/a | -₹2b |
| Jun 30 2019 | n/a | n/a | -₹2b |
| Mar 31 2019 | ₹24m | ₹24m | -₹3b |
| Dec 31 2018 | n/a | n/a | -₹3b |
| Sep 30 2018 | n/a | n/a | -₹3b |
| Jun 30 2018 | n/a | n/a | -₹3b |
| Mar 31 2018 | ₹24m | ₹19m | -₹6b |
Tazminat ve Piyasa: Murtaza 'nin toplam tazminatı ($USD 251.56K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 590.32K ).
Tazminat ve Kazançlar: Murtaza 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Murtaza Khorakiwala (51 yo)
15.6yrs
Görev süresi
₹21,200,000
Tazminat
Dr. Murtaza Habil Khorakiwala serves as the Managing Director of Wockhardt Ltd. since April 2009 and has been its Executive Director since March 31, 2009. Dr. Khorakiwala serves as a Director of Khorakiwal...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder & Executive Chairman | 20.8yrs | ₹36.50m | 0.37% ₹ 773.5m | |
| MD & Executive Director | 15.6yrs | ₹21.20m | 0.18% ₹ 380.8m | |
| Executive Director | 15.6yrs | ₹21.20m | 0.17% ₹ 363.7m | |
| Chief Financial Officer | 2.4yrs | Veri yok | 0.0080% ₹ 16.8m | |
| Chief Scientific Officer of New Drug Discovery | no data | ₹1.71m | 0.036% ₹ 75.5m | |
| Senior Vice President of Legal | no data | Veri yok | 0.0077% ₹ 16.3m | |
| Chief Human Resource Officer | no data | Veri yok | Veri yok | |
| Senior Vice President of Business Development | no data | ₹1.61m | Veri yok | |
| Head of Global Regulatory Affairs | 10.8yrs | Veri yok | Veri yok | |
| President of Supply Chain | no data | Veri yok | Veri yok | |
| Managing Director of Wockhardt UK | no data | Veri yok | Veri yok | |
| President of Manufacturing | no data | Veri yok | Veri yok |
15.6yrs
Ortalama Görev Süresi
57yo
Ortalama Yaş
Deneyimli Yönetim: WOCKPHARMA 'un yönetim ekibi deneyimli ve deneyimlidir ( 15.6 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder & Executive Chairman | 20.8yrs | ₹36.50m | 0.37% ₹ 773.5m | |
| MD & Executive Director | 15.7yrs | ₹21.20m | 0.18% ₹ 380.8m | |
| Executive Director | 15.6yrs | ₹21.20m | 0.17% ₹ 363.7m | |
| Non-Executive Independent Director | 4.3yrs | ₹1.10m | Veri yok | |
| Non-Executive & Independent Director | 8yrs | ₹1.70m | Veri yok | |
| Non-Executive Non- Independent Director | 7.1yrs | ₹300.00k | Veri yok | |
| Non Executive Independent Director | less than a year | Veri yok | 0.00012% ₹ 252.5k | |
| Independent Director | 1.3yrs | ₹1.00m | 0.000060% ₹ 126.2k |
7.5yrs
Ortalama Görev Süresi
66.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: WOCKPHARMA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.5 yıldır).